BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34053163)

  • 1. Treatment patterns and clinical outcomes among patients <65 years with a worsening heart failure event.
    Butler J; Yang M; Sawhney B; Chakladar S; Yang L; Djatche LM
    Eur J Heart Fail; 2021 Aug; 23(8):1334-1342. PubMed ID: 34053163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Economic Burden of Chronic Heart Failure and Reduced Ejection Fraction Following a Worsening Heart Failure Event.
    Butler J; Djatche LM; Sawhney B; Chakladar S; Yang L; Brady JE; Yang M
    Adv Ther; 2020 Sep; 37(9):4015-4032. PubMed ID: 32761552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality outcomes, healthcare resource utilization and costs in Medicare patients with chronic heart failure with reduced ejection fraction with and without a worsening event.
    Mentz RJ; Pulungan Z; Kim S; Yang M; Teigland C; Hilkert R; Djatche LM
    J Med Econ; 2021; 24(1):698-705. PubMed ID: 33900874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication Trajectory and Treatment Patterns in Medicare Patients With Heart Failure and Reduced Ejection Fraction.
    Mentz RJ; Lautsch D; Pulungan Z; Kim S; Hilkert R; Teigland C; Yang M; Djatche L
    J Card Fail; 2022 Aug; 28(8):1349-1354. PubMed ID: 34930657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Out-of-pocket payments for part d covered medications by medicare fee-for-service beneficiaries with heart failure with reduced ejection fraction.
    Fendrick AM; Djatche L; Pulungan Z; Teigland C; Yang M; Lautsch D; Hilkert R; Mentz R
    Am Heart J; 2022 Apr; 246():74-81. PubMed ID: 34774543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-B-type natriuretic peptide concentrations, testing and associations with worsening heart failure events.
    Ferrannini G; Benson L; Lautsch D; Dahlström U; Lund LH; Savarese G; Carrero JJ
    ESC Heart Fail; 2024 Apr; 11(2):759-771. PubMed ID: 38115625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Clinical outcome results from the CHART-HF study.
    Gaggin HK; Greene SJ; Zhou M; Lautsch D; Bash LD; Djatche L; Song Y; Signorovitch J; Stevenson AS; Blaustein RO; Butler J
    Int J Cardiol Cardiovasc Risk Prev; 2024 Jun; 21():200278. PubMed ID: 38766664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-B-type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction.
    Januzzi JL; Tan X; Yang L; Brady JE; Yang M; Banka P; Lautsch D
    ESC Heart Fail; 2022 Feb; 9(1):87-99. PubMed ID: 34918487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Rationale and design of the CHART-HF study.
    Greene SJ; Lautsch D; Gaggin HK; Djatche LM; Zhou M; Song Y; Signorovitch J; Stevenson AS; Blaustein RO; Butler J
    Am Heart J; 2022 Sep; 251():127-136. PubMed ID: 35640728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event.
    Alsumali A; Lautsch D; Liu R; Patel D; Nanji S; Djatche LM
    Adv Ther; 2021 May; 38(5):2631-2643. PubMed ID: 33860924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study.
    Ru B; Tan X; Liu Y; Kannapur K; Ramanan D; Kessler G; Lautsch D; Fonarow G
    JMIR Form Res; 2023 Apr; 7():e41775. PubMed ID: 37067873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment patterns of patients with worsening heart failure with reduced ejection fraction.
    Greene SJ; Gaggin HK; Zhou M; Bash LD; Lautsch D; Djatche L; Song Y; Signorovitch J; Stevenson AS; Blaustein RO; Butler J
    ESC Heart Fail; 2024 Apr; ():. PubMed ID: 38639469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.
    Butler J; Yang M; Manzi MA; Hess GP; Patel MJ; Rhodes T; Givertz MM
    J Am Coll Cardiol; 2019 Mar; 73(8):935-944. PubMed ID: 30819362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-centered Outcomes in HFrEF Following a Worsening Heart Failure Event: A Survey Analysis.
    Dunbar SB; Tan X; Lautsch D; Yang M; Ricker B; Maculaitis MC; Nagle T; Clark LT; Hilkert R; Brady JE; Spertus JA
    J Card Fail; 2021 Aug; 27(8):877-887. PubMed ID: 34364664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event.
    Givertz MM; Yang M; Hess GP; Zhao B; Rai A; Butler J
    ESC Heart Fail; 2021 Jun; 8(3):1915-1923. PubMed ID: 33689217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 19. Representativeness of the VICTORIA Trial Population in Clinical Practice: Analysis of the PINNACLE Registry.
    Butler J; Djatche LM; Lautsch D; Yang L; Patel MJ; Mentz RJ
    J Card Fail; 2021 Dec; 27(12):1374-1381. PubMed ID: 34271161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient treatment of worsening heart failure with intravenous diuretics: first results from a multicentre 2-year experience.
    Wierda E; van Maarschalkerwaart WWA; van Seumeren E; Dickhoff C; Montanus I; de Boer D; Kop E; de Mol BAJM; Schroeder-Tanka JM; van Heerbeek L
    ESC Heart Fail; 2023 Feb; 10(1):594-600. PubMed ID: 36377206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.